What are the side effects of Ebglyss (Lebrikizumab)?

Ebglyss (Lebrikizumab) is a treatment for moderate to severe atopic dermatitis (AD, atopic eczema), indicated for adults and children 12 years and older and weighing at least 40 kilograms. Atopic dermatitis is a common skin disease in which patients often experience uncomfortable symptoms such as itching, dryness, and redness. The use of this drug is mainly aimed at patients who cannot obtain timely and effective treatment through topical drugs.

Ebglyss' active ingredient, lebrikizumab, is a monoclonal antibody designed to neutralize high levels of interleukin 13 (IL-13) in the body. IL-13 is a protein that promotes skin inflammation, and excess IL-13 causes the classic symptoms of atopic dermatitis. By inhibiting the effects of IL-13, lebrikizumab can effectively relieve related symptoms and improve patients' quality of life.

In clinical studies of Ebglyss, some side effects were observed. The most common of these are inflammatory reactions of the eyes and eyelids, including dry eye and conjunctivitis. These symptoms include redness, swelling, and itching of the eyes. In addition, injection site reactions are also one of the more common side effects, and patients may feel pain or discomfort. It is worth noting that the incidence of herpes zoster has also increased, and some patients may develop symptoms of allergic conjunctivitis.

When using Ebglyss, patients need to pay special attention to the following points. First of all, Ebglyss is not suitable for patients who are allergic to lebrikizumab or its ingredients, so before treatment, doctors should understand the patient's allergic history in detail to ensure the safety of the medication. Secondly, patients need to be followed up regularly during treatment to monitor any potential adverse reactions and adjust the treatment plan in a timely manner.

AlthoughEbglyss brings new treatment options, patients should be fully informed of possible side effects and how to manage them before starting treatment. In the process of using Ebglyss, communication between doctors and patients is crucial to ensure that patients can report any symptoms of discomfort in a timely manner so that appropriate treatment can be carried out.